How Accurate Is Myriad Gender Testing

Non-invasive prenatal testing (NIPT) has revolutionized prenatal care by offering expectant parents early insights into the genetic health of their developing baby. One of the optional components of NIPT is fetal sex determination, often referred to as gender testing. While generally highly accurate, it's crucial to understand the principles behind this testing and the factors that can influence its results.

The Science Behind Myriad Gender Testing

Myriad's Prequel prenatal screen, like other NIPTs, analyzes cell-free fetal DNA (cffDNA) circulating in the mother's blood. During pregnancy, a small fraction of the DNA in a pregnant woman's bloodstream comes from the placenta, which shares the baby's genetic makeup. NIPT examines this cffDNA to screen for chromosomal abnormalities like Down syndrome. Gender determination is achieved by detecting the presence or absence of the Y chromosome.

Here's how it works:

• Sample Collection: A blood sample is drawn from the pregnant woman, typically after 10 weeks of gestation.
• DNA Extraction: cffDNA is extracted from the blood sample.
• Y Chromosome Detection: The lab analyzes the cffDNA for the presence of the Y chromosome. Specialized techniques, often involving polymerase chain reaction (PCR) or next-generation sequencing (NGS), are used to identify Y-chromosome-specific sequences.
• Result Interpretation:
  • If Y-chromosome sequences are detected, the fetus is presumed to be male.
  • If Y-chromosome sequences are not detected, the fetus is presumed to be female.

Accuracy Rates

NIPT for fetal sex determination is generally considered to be highly accurate, with reported accuracy rates often exceeding 99%. However, it's vital to understand that this accuracy is not 100%, and certain factors can affect the reliability of the results.

Factors Influencing Accuracy

Several factors can potentially lead to inaccurate fetal sex determination results:

• Gestational Age: Testing too early in the pregnancy (before 10 weeks) can result in a lower concentration of cffDNA in the mother's blood. This can increase the risk of a false negative result (incorrectly indicating a female fetus). Most labs recommend waiting until at least 10 weeks for optimal accuracy.
• Technical Errors: As with any laboratory test, there's a small chance of technical errors during sample collection, processing, or analysis. These errors can lead to either false positive or false negative results. Stringent quality control measures are essential to minimize these risks.
• Vanishing Twin Syndrome: If the pregnancy initially involved twins and one twin demised early in the pregnancy (vanishing twin syndrome), cffDNA from the demised twin could still be present in the mother's blood. If the demised twin was male, it could lead to a false positive result (incorrectly indicating a male fetus), even if the surviving twin is female.
• Maternal Mosaicism: In rare cases, the mother may have a condition called maternal mosaicism, where some of her cells contain a Y chromosome. This can lead to a false positive result, as the Y chromosome detected in the blood sample may be from the mother's cells rather than the fetus's.
• Prior Male Pregnancies: While less of a factor than the others, fetal DNA from prior male pregnancies can persist in the maternal circulation for a brief period. The remnants are unlikely to affect NIPT after several months or years have elapsed since the previous pregnancy.

Understanding False Positives and False Negatives

It's important to differentiate between false positive and false negative results:

• False Positive: A false positive occurs when the test indicates the presence of a Y chromosome (suggesting a male fetus) when the fetus is actually female. This can happen due to factors like vanishing twin syndrome or maternal mosaicism, as described above.
• False Negative: A false negative occurs when the test fails to detect the Y chromosome (suggesting a female fetus) when the fetus is actually male. This is more likely to occur earlier in the pregnancy when the concentration of cffDNA is lower or due to technical errors.

Confirmation and Clinical Significance

While NIPT is highly accurate, it is still a screening test, not a diagnostic test. This means that a positive result (indicating a potential issue) should be confirmed with a diagnostic test like amniocentesis or chorionic villus sampling (CVS). However, for gender determination, these invasive tests are generally not recommended solely for confirmation purposes due to the associated risks of miscarriage.

Most healthcare providers rely on ultrasound to confirm the fetal sex identified by NIPT. An ultrasound performed around 18-20 weeks of gestation can usually visualize the fetal genitalia with sufficient clarity to confirm the sex. However, in rare cases, ultrasound may also be inconclusive, especially if the fetal position is not ideal.

It is important to note that NIPT is primarily intended for screening for chromosomal abnormalities. Fetal sex determination is often an incidental finding or an optional component of the test. The clinical significance of accurate fetal sex determination lies primarily in:

• Family Planning: Parents may want to know the sex of their baby for personal or cultural reasons.
• X-linked Genetic Disorders: Knowing the fetal sex is crucial when there is a family history of X-linked genetic disorders. These disorders are caused by genes located on the X chromosome and typically affect males more severely than females. If the fetus is male, there is a higher risk of inheriting the disorder.

What to Discuss with Your Healthcare Provider

Before undergoing NIPT, it's essential to have a thorough discussion with your healthcare provider. This discussion should include:

• The purpose of the test: Understand that NIPT is primarily a screening test for chromosomal abnormalities.
• Accuracy rates: Be aware that NIPT for fetal sex determination is highly accurate but not 100%.
• Potential limitations: Discuss the factors that can influence the accuracy of the test, such as gestational age and vanishing twin syndrome.
• Confirmation options: Understand how the fetal sex, if desired, will be confirmed (typically by ultrasound).
• Informed consent: Make an informed decision about whether or not to include fetal sex determination as part of the NIPT screening.

It is also crucial to understand that using NIPT solely for sex selection raises ethical concerns. Most healthcare providers discourage this practice.

The Importance of Accurate Gender Testing

While the accuracy of Myriad’s Prequel test (and other NIPTs) for gender determination is generally high, it's important to recognize that no test is perfect. Understanding the science behind the test, the factors that can influence its accuracy, and the limitations of screening tests is essential for informed decision-making during pregnancy. Discussing your individual risk factors and preferences with your healthcare provider will ensure you receive the best possible prenatal care.